The role m6A RNA methylation is CNS development and glioma pathogenesis

Epigenetic abnormalities play a crucial role in many tumors, including glioma. RNA methylation occurs as an epigenetic modification similar to DNA methylation and histone modification. m(6)A methylation is the most common and most intensively studied RNA methylation, which can be found throughout the RNA life cycle and exert biological functions by affecting RNA metabolism. The m(6)A modification is primarily associated with three types of protease, which are encoded by the writer, eraser and reader genes, respectively. It has been shown that the m(6)A methylation has close connections with the occurrence and development of many tumors, including glioma. In this study, the concept and the research progress of m(6)A methylation are reviewed, especially the role of m(6)A methylation in glioma. Moreover, we will discuss how glioma is paving the way to the development of new therapeutic options based on the inhibition of m(6)A deposition.

Automated summary

Epigenetic abnormalities, particularly RNA methylation, play a crucial role in tumors such as glioma. The m(6)A methylation, the most common form of RNA methylation, is closely associated with the occurrence and development of various tumors, including glioma. In-depth research on the mechanisms of m(6)A methylation may lead to the development of new therapeutic options for glioma based on the inhibition of m(6)A deposition.